Potential effect of zoledronate therapy in heavy proteinuria [2]

Clinical Nephrology

Volumn 67, Issue 4, 2007, Pages 263-265

  Gokden, N ^a   Zangari, M ^b   Elici, F ^b   Barlogie, B ^b   Kumar, J ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; MELPHALAN; PAMIDRONIC ACID; PREDNISOLONE; ZOLEDRONIC ACID;

ADULT; ANAMNESIS; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; DOSE TIME EFFECT RELATION; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GLOMERULOPATHY; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY FAILURE; LABORATORY TEST; LETTER; LOW DRUG DOSE; MULTIPLE MYELOMA; NEPHROSCLEROSIS; PROTEINURIA; TREATMENT DURATION;

EID: 34247214656     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp67263     Document Type: Letter

References (10)

1. Barisoni L, Kriz W, Mundel P, D'Agati V. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol. 1999; 10: 51-61.
2. Barri YM, Munshi NC, Sukumalchantra S, Abulezz SR, Bonsib SM, Wallach J, Walker PD. Podocyte injury-associated glomerulopathies induced by pamidronate. Kidney Int. 2004; 65: 634-641.
3. Chang JT, Lanh G, Beitz L. Renal failure with the use of zoledronic acid (correspondence). N Engl J Med. 2003; 349: 1676-1679.
4. Coroneos E, Petrusevska G, Varghese F, Truong LD. Focal segmental glomerulosclerosis with acute renal failure associated with alpha-interferon therapy. Am J Kidney Dis. 1996; 28: 888-892.
5. D'Agati VD, Suh J-I, Carbone L, Cheng JT, Appel G. Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study. Kidney Int. 1989; 35: 1358-1370.
6. Markowitz GS, Fine PL, Stack JI et al. Toxic acute tubular necrosis following treatment with zoledronate (zometa). Kidney Int. 2003; 64: 281-289.
7. Markowitz GS, Appel GB, Fine PL et al. Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J Am Soc Nephrol. 2001; 12: 1164-1172.
8. Moudgil A, Nast CC, Bagga A et al. Association of Parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int. 2001; 59: 2126-2133.
9. Stein DF, Ahmed A, Sunkhara V, Khalbuss W. Collapsing focal segmental glomerulosclerosis with recovery of renal function: an uncommon complication of interferon therapy for hepatitis C. Dig Dis Sci. 2001; 46: 530-535.
10. Valeri A, Barisoni L, Appel GB, Seigle R, D'Agati V. Idiopathic collapsing focal segmental glomerulosclerosis: a clinico-pathologic study. Kidney Int. 1996; 50: 1734-1746.